Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 3
1975 1
1979 1
1988 1
1992 1
1993 1
1996 1
1998 2
1999 1
2002 1
2003 3
2004 5
2005 1
2006 2
2007 1
2008 3
2009 3
2010 1
2011 1
2012 2
2014 4
2015 3
2016 7
2017 3
2018 2
2019 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
The ins and outs of molecular pathology reporting.
Tack V, Dufraing K, Deans ZC, van Krieken HJ, Dequeker EMC. Tack V, et al. Among authors: van krieken hj. Virchows Arch. 2017 Aug;471(2):199-207. doi: 10.1007/s00428-017-2108-0. Epub 2017 Mar 26. Virchows Arch. 2017. PMID: 28343306 Review.
Guidance for laboratories performing molecular pathology for cancer patients.
Cree IA, Deans Z, Ligtenberg MJ, Normanno N, Edsjö A, Rouleau E, Solé F, Thunnissen E, Timens W, Schuuring E, Dequeker E, Murray S, Dietel M, Groenen P, Van Krieken JH; European Society of Pathology Task Force on Quality Assurance in Molecular Pathology; Royal College of Pathologists. Cree IA, et al. J Clin Pathol. 2014 Nov;67(11):923-31. doi: 10.1136/jclinpath-2014-202404. Epub 2014 Jul 10. J Clin Pathol. 2014. PMID: 25012948 Free PMC article. Review.
Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL.
Deans ZC, Costa JL, Cree I, Dequeker E, Edsjö A, Henderson S, Hummel M, Ligtenberg MJ, Loddo M, Machado JC, Marchetti A, Marquis K, Mason J, Normanno N, Rouleau E, Schuuring E, Snelson KM, Thunnissen E, Tops B, Williams G, van Krieken H, Hall JA; IQN Path ASBL. Deans ZC, et al. Among authors: van krieken h. Virchows Arch. 2017 Jan;470(1):5-20. doi: 10.1007/s00428-016-2025-7. Epub 2016 Sep 27. Virchows Arch. 2017. PMID: 27678269 Free PMC article. Review.
Quality assurance in clinical trials.
Ottevanger PB, Therasse P, van de Velde C, Bernier J, van Krieken H, Grol R, De Mulder P. Ottevanger PB, et al. Among authors: van krieken h. Crit Rev Oncol Hematol. 2003 Sep;47(3):213-35. doi: 10.1016/s1040-8428(03)00028-3. Crit Rev Oncol Hematol. 2003. PMID: 12962897 Review.
[Tumour examination to detect hereditary colorectal cancer].
Hoogerbrugge N, Hermens RP, Nagengast F, Overbeek L, van Krieken HJ, Ligtenberg M. Hoogerbrugge N, et al. Among authors: van krieken hj. Ned Tijdschr Geneeskd. 2012;156(42):A4982. Ned Tijdschr Geneeskd. 2012. PMID: 23075775 Review. Dutch.
Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer.
van de Weerd S, Torang A, van den Berg I, Lammers V, van den Bergh S, Brouwer N, Nagtegaal ID, Koopman M, Vink GR, van der Baan FH, van Krieken H, Koster J, Ijzermans JN, Roodhart JML, Medema JP. van de Weerd S, et al. Among authors: van krieken h. Int J Cancer. 2025 Jan 15;156(2):456-466. doi: 10.1002/ijc.35120. Epub 2024 Aug 8. Int J Cancer. 2025. PMID: 39115332 Free PMC article.
53 results